PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-44.75%
Negative revenue growth while ANO.AX stands at 62.13%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-44.75%
Negative gross profit growth while ANO.AX is at 251.94%. Joel Greenblatt would examine cost competitiveness or demand decline.
282.29%
EBIT growth above 1.5x ANO.AX's 155.25%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
282.29%
Operating income growth under 50% of ANO.AX's 648.74%. Michael Burry would be concerned about deeper cost or sales issues.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.77%
Share count expansion well above ANO.AX's 0.62%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
5.77%
Diluted share count expanding well above ANO.AX's 0.46%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-28.49%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-26.96%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-93.18%
Negative 10Y revenue/share CAGR while ANO.AX stands at 223.10%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-93.18%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
359.22%
3Y revenue/share CAGR above 1.5x ANO.AX's 6.96%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
38.59%
10Y OCF/share CAGR under 50% of ANO.AX's 77.99%. Michael Burry would worry about a persistent underperformance in cash creation.
38.59%
Positive OCF/share growth while ANO.AX is negative. John Neff might see a comparative advantage in operational cash viability.
23.81%
3Y OCF/share CAGR under 50% of ANO.AX's 878.66%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-100.00%
Negative 10Y net income/share CAGR while ANO.AX is at 4293.06%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-100.00%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We cut SG&A while ANO.AX invests at 14.86%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.